Long Focus Capital Management LLC 13D and 13G filings for Adaptimmune Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 4:40 pm Purchase |
2024-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Long Focus Capital Management LLC | 20,494,393 8.000% |
8,407,478 (+69.56%) |
Filing |
| 2024-02-14 5:04 pm Purchase |
2023-12-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Long Focus Capital Management LLC | 12,086,915 5.300% |
774,568 (+6.85%) |
Filing |
| 2023-11-08 12:59 pm Purchase |
2023-10-31 | 13G | Adaptimmune Therapeutics plc ADAP |
Long Focus Capital Management LLC | 11,312,347 5.000% |
11,312,347 (New Position) |
Filing |